Nizar A. Al‐Shar’i

959 total citations
48 papers, 650 citations indexed

About

Nizar A. Al‐Shar’i is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Nizar A. Al‐Shar’i has authored 48 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 14 papers in Computational Theory and Mathematics and 10 papers in Organic Chemistry. Recurrent topics in Nizar A. Al‐Shar’i's work include Computational Drug Discovery Methods (14 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Synthesis and biological activity (4 papers). Nizar A. Al‐Shar’i is often cited by papers focused on Computational Drug Discovery Methods (14 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Synthesis and biological activity (4 papers). Nizar A. Al‐Shar’i collaborates with scholars based in Jordan, India and South Africa. Nizar A. Al‐Shar’i's co-authors include Qosay Al‐Balas, Rana Obaidat, Ammar Almaaytah, Mohammad A. Hassan, Pran Kishore Deb, Pobitra Borah, Katharigatta N. Venugopala, Tamam El‐Elimat, Shadi Tarazi and Vinayak Singh and has published in prestigious journals such as Molecules, International Journal of Biological Macromolecules and Current Medicinal Chemistry.

In The Last Decade

Nizar A. Al‐Shar’i

46 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nizar A. Al‐Shar’i Jordan 16 331 144 114 105 65 48 650
Sisir Nandi India 15 290 0.9× 228 1.6× 86 0.8× 242 2.3× 13 0.2× 98 829
Rajesh B. Patil India 17 442 1.3× 255 1.8× 152 1.3× 261 2.5× 25 0.4× 89 1.2k
Sako Mirzaie Iran 17 377 1.1× 98 0.7× 149 1.3× 144 1.4× 20 0.3× 47 857
Qosay Al‐Balas Jordan 19 662 2.0× 163 1.1× 48 0.4× 107 1.0× 340 5.2× 68 1.0k
Daigo Inoyama United States 9 591 1.8× 164 1.1× 39 0.3× 44 0.4× 53 0.8× 11 750
Céline Crauste France 17 296 0.9× 200 1.4× 156 1.4× 40 0.4× 10 0.2× 36 688
Leonardo Baldassarre Italy 12 272 0.8× 103 0.7× 47 0.4× 19 0.2× 78 1.2× 14 476
Kalicharan Sharma India 16 273 0.8× 221 1.5× 190 1.7× 80 0.8× 6 0.1× 70 822
Sandeep Lohan India 14 352 1.1× 230 1.6× 40 0.4× 66 0.6× 146 2.2× 34 709

Countries citing papers authored by Nizar A. Al‐Shar’i

Since Specialization
Citations

This map shows the geographic impact of Nizar A. Al‐Shar’i's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar A. Al‐Shar’i with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar A. Al‐Shar’i more than expected).

Fields of papers citing papers by Nizar A. Al‐Shar’i

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nizar A. Al‐Shar’i. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar A. Al‐Shar’i. The network helps show where Nizar A. Al‐Shar’i may publish in the future.

Co-authorship network of co-authors of Nizar A. Al‐Shar’i

This figure shows the co-authorship network connecting the top 25 collaborators of Nizar A. Al‐Shar’i. A scholar is included among the top collaborators of Nizar A. Al‐Shar’i based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nizar A. Al‐Shar’i. Nizar A. Al‐Shar’i is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venugopala, Katharigatta N., Sandeep Chandrashekharappa, Pran Kishore Deb, et al.. (2024). Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies. International Journal of Biological Macromolecules. 274(Pt 2). 133285–133285. 7 indexed citations
2.
Al‐Shar’i, Nizar A.. (2024). The design of TOPK inhibitors using similarity search, molecular docking, and MD simulations. Journal of Biomolecular Structure and Dynamics. 43(15). 8456–8467. 1 indexed citations
3.
Al‐Shar’i, Nizar A., Viresh Mohanlall, Raquel M. Gleiser, et al.. (2024). Synthesis, characterization and larvicidal studies of ethyl 3-benzoyl-7-(piperidin-1-yl)indolizine-1-carboxylate analogues against Anopheles arabiensis and cheminformatics approaches. Journal of Biomolecular Structure and Dynamics. 43(15). 8142–8154. 8 indexed citations
4.
Hourani, Wafa, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.. (2024). Anticancer and Cyclooxygenase Inhibitory Activity of Benzylidene Derivatives of Fenobam and its Thio Analogues. Current Medicinal Chemistry. 33(5). 1054–1075.
5.
Al‐Shar’i, Nizar A., Sandeep Chandrashekharappa, Pran Kishore Deb, et al.. (2023). Synthesis, biological evaluation, and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis. Journal of Biomolecular Structure and Dynamics. 42(8). 4016–4028. 5 indexed citations
6.
7.
Al‐Shar’i, Nizar A., et al.. (2022). The impact of cycleanine in cancer research: a computational study. Journal of Molecular Modeling. 28(11). 340–340. 2 indexed citations
8.
Venugopala, Katharigatta N., Nizar A. Al‐Shar’i, Lina A. Dahabiyeh, et al.. (2022). Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics. 11(7). 831–831. 6 indexed citations
9.
Obaidat, Rana, et al.. (2022). Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin. Research in Pharmaceutical Sciences. 17(4). 334–349. 8 indexed citations
10.
11.
Borah, Pobitra, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.. (2021). Perspectives on RNA Vaccine Candidates for COVID-19. Frontiers in Molecular Biosciences. 8. 635245–635245. 40 indexed citations
12.
Deb, Pran Kishore, Nizar A. Al‐Shar’i, Katharigatta N. Venugopala, Melendhran Pillay, & Pobitra Borah. (2021). In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 869–884. 38 indexed citations
13.
Al‐Shar’i, Nizar A., et al.. (2020). Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking. Molecules. 25(12). 2871–2871. 5 indexed citations
14.
Al‐Shar’i, Nizar A., et al.. (2020). Discovery of Novel Glyoxalase-I Inhibitors Using Computational Fragment-Based Drug Design Approach. Jordan Journal of Pharmaceutical Sciences. 13(2). 3 indexed citations
15.
Al‐Shar’i, Nizar A., et al.. (2019). Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking. Journal of Computer-Aided Molecular Design. 33(9). 799–815. 18 indexed citations
16.
Al‐Balas, Qosay, et al.. (2018). Design, Synthesis and Biological Evaluation of Potential Novel Zinc Binders Targeting Human Glyoxalase-I; A Validated Target for Cancer Treatment. Jordan Journal of Pharmaceutical Sciences. 11(1). 4 indexed citations
17.
Al‐Balas, Qosay, Mohammad A. Hassan, Nizar A. Al‐Shar’i, Tamam El‐Elimat, & Ammar Almaaytah. (2017). Computational and experimental exploration of the structure–activity relationships of flavonoids as potent glyoxalase‐I inhibitors. Drug Development Research. 79(2). 58–69. 17 indexed citations
18.
Obaidat, Rana, et al.. (2016). Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches. Pharmaceutical Development and Technology. 23(10). 986–997. 16 indexed citations
19.
Al‐Shar’i, Nizar A., Mohammad A. Hassan, & Qosay Al‐Balas. (2015). Identification of Possible Glyoxalase II Inhibitors as Anticancer Agents by a Customized 3D Structure-Based Pharmacophore Model. Jordan Journal of Pharmaceutical Sciences. 8(2). 4 indexed citations
20.
Almaaytah, Ammar, et al.. (2014). Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1. Pharmaceuticals. 7(5). 502–516. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sisir Nandi Breakdown of academic impact, for papers by Rajesh B. Patil Breakdown of academic impact, for papers by Sako Mirzaie Breakdown of academic impact, for papers by Qosay Al‐Balas Breakdown of academic impact, for papers by Daigo Inoyama Breakdown of academic impact, for papers by Céline Crauste Breakdown of academic impact, for papers by Leonardo Baldassarre Breakdown of academic impact, for papers by Kalicharan Sharma Breakdown of academic impact, for papers by Sandeep Lohan
Rankless by CCL
2026